PT - JOURNAL ARTICLE AU - Bsat, Raghid AU - Chemaitelly, Hiam AU - Coyle, Peter AU - Tang, Patrick AU - Hasan, Mohammad R. AU - Al Kanaani, Zaina AU - Al Kuwari, Einas AU - Butt, Adeel A. AU - Jeremijenko, Andrew AU - Kaleeckal, Anvar Hassan AU - Latif, Ali Nizar AU - Shaik, Riyazuddin Mohammad AU - Nasrallah, Gheyath K. AU - Benslimane, Fatiha M. AU - Al Khatib, Hebah A. AU - Yassine, Hadi M. AU - Al Kuwari, Mohamed G. AU - Al Romaihi, Hamad Eid AU - Al-Thani, Mohamed H. AU - Al Khal, Abdullatif AU - Bertollini, Roberto AU - Abu-Raddad, Laith J. AU - Ayoub, Houssein H. TI - Characterizing the effective reproduction number during the COVID-19 epidemic: Insights from Qatar’s experience AID - 10.1101/2021.10.07.21264599 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.07.21264599 4099 - http://medrxiv.org/content/early/2021/10/07/2021.10.07.21264599.short 4100 - http://medrxiv.org/content/early/2021/10/07/2021.10.07.21264599.full AB - Background The effective reproduction number, Rt, is a tool to track and understand epidemic dynamics. This investigation of Rt estimations was conducted to guide the national COVID-19 response in Qatar, from the onset of the epidemic until August 18, 2021.Methods Real-time “empirical” was estimated using five methods, including the Robert Koch Institute, Cislaghi, Systrom-Bettencourt and Ribeiro, Wallinga and Teunis, and Cori et al. methods. R was also estimated using a transmission dynamics model . Uncertainty and sensitivity analyses were conducted. Agreements between different Rt estimates were assessed by calculating correlation coefficients.Results captured the evolution of the epidemic through three waves, public health response landmarks, effects of major social events, transient fluctuations coinciding with significant clusters of infection, and introduction and expansion of the B.1.1.7 variant. The various estimation methods produced consistent and overall comparable estimates with generally large correlation coefficients. The Wallinga and Teunis method was the fastest at detecting changes in epidemic dynamics. estimates were consistent whether using time series of symptomatic PCR-confirmed cases, all PCR-confirmed cases, acute-care hospital admissions, or ICU-care hospital admissions, to proxy trends in true infection incidence. correlated strongly with and provided an average .Conclusions Rt estimations were robust and generated consistent results regardless of the data source or the method of estimation. Findings affirmed an influential role for Rt estimations in guiding national responses to the COVID-19 pandemic, even in resource-limited settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementHHA and RB acknowledge the joint support of Qatar University and Marubeni M-QJRC-2020-5. The authors are grateful for support provided by the Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core, both at Weill Cornell Medicine-Qatar, as well as for support provided by the Ministry of Public Health and Hamad Medical Corporation. The developed mathematical models were made possible by NPRP grant number 9-040-3-008 (Principal investigator: LJA) and NPRP grant number 12S-0216-190094 (Principal investigator: LJA) from the Qatar National Research Fund (a member of Qatar Foundation; https://www.qnrf.org). The authors are also grateful for the Qatar Genome Programme for institutional support for the reagents needed for the viral genome sequencing. The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Hamad Medical Corporation and Weill Cornell Medicine-Qatar Institutional Review Boards with waiver of informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset of this study is a property of the Qatar Ministry of Public Health that was provided to the researchers through a restricted-access agreement that prevents sharing the dataset with a third party or publicly. Future access to this dataset can be considered through a direct application for data access to Her Excellency the Minister of Public Health (https://www.moph.gov.qa/english/Pages/default.aspx).